发明名称 Low Affinity FCGR Deficient Mice
摘要 Genetically modified non-human animals and methods and compositions for making and using them are provided, wherein the genetic modification comprises a deletion of the endogenous low affinity FcγR locus, and wherein the mouse is capable of expressing a functional FcRγ-chain. Genetically modified mice are described, including mice that express low affinity human FcγR genes from the endogenous FcγR locus, and wherein the mice comprise a functional FcRγ-chain. Genetically modified mice that express up to five low affinity human FcγR genes on accessory cells of the host immune system are provided.
申请公布号 US2015313195(A1) 申请公布日期 2015.11.05
申请号 US201514800253 申请日期 2015.07.15
申请人 Regeneron Pharmaceuticals, Inc. 发明人 Macdonald Lynn;Tu Naxin;Gurer Cagan;Stevens Sean;Murphy Andrew J.
分类号 A01K67/027 主分类号 A01K67/027
代理机构 代理人
主权项 1. A transgenic mouse whose genome comprises a contiguous human nucleotide sequence that encodes at least two α-chains of a human FcγR α-chain gene selected from FcγRIIA, FcγRIIB, FcγRIIC, FcγRIIIA, FcγRIIIB, and a combination thereof, wherein the contiguous human nucleotide sequence replaces mouse FcγR sequences in a mouse FcγR locus, and wherein the mouse comprises a functional FcR γ-chain gene.
地址 Tarrytown NY US